NCT00730119

Brief Summary

This investigation is a multi-center study that will demonstrate that the GE Monitor meets equivalency and/or accuracy and/or performance criteria. This investigation will compare the test device(s) to itself, or one of the reference parameters, or a combination of parameters, including NIBP, temperature, SpO2, respirations, and ECG.

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Oct 2001

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2001

Completed
6.8 years until next milestone

First Submitted

Initial submission to the registry

August 5, 2008

Completed
3 days until next milestone

First Posted

Study publicly available on registry

August 8, 2008

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2010

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2010

Completed
Last Updated

August 8, 2017

Status Verified

August 1, 2017

Enrollment Period

8.4 years

First QC Date

August 5, 2008

Last Update Submit

August 7, 2017

Conditions

Keywords

Non-invasive Blood Pressure (NIBP)GE MonitorTemperatureSpO2Respiration, ECG

Outcome Measures

Primary Outcomes (1)

  • This investigation will compare values from the test device(s) to itself, or one of the reference parameters, or a combination of parameters, including NIBP, temperature, SpO2, respirations, and ECG.

    unlimited

Study Arms (3)

Neonates

Subjects ages birth to 30 days

Infants

Subjects aged \>30 days to 2 years

Adults

Subjects aged 18 years of age or older

Eligibility Criteria

Age1 Minute+
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All populations (neonatal, pediatrics, and adults).

You may qualify if:

  • Signed informed consent from subject and/or guardian
  • Ability to maintain proper placement of cuff and/or probe and/or sensor
  • Presence of atrial fibrillation or other irregular heart rhythm (when applicable)
  • Ability to single or dual monitor NIBP, ECG, and/or SpO2, whether or not already being monitored for any or all of these parameters (SuperSTAT development study only)

You may not qualify if:

  • Any subject deemed too unstable, by clinician's discretion, or for another reason deemed unacceptable for study by the clinician
  • Known dysrhythmias (when applicable)
  • Known disease state or medical condition that A) compromises circulation to the extremity, B) compromises musculo-skeletal integrity, or C) otherwise contraindicates use of a NIBP cuff and/or SpO2 sensor on an extremity or ECG patches on skin
  • Vigorous exercise prior to participating in the study
  • Excessive movement or excitability causing false values or no determinations
  • Known allergy to latex when latex products will be in contact with subject
  • Subjects who have eaten, drank, smoked or chewed gum in the preceding half hour (temperature parameter only)
  • Nasal/septal defects, cold and/or allergies that would not allow the subject to breathe through their nose (temperature parameter only)
  • Subjects with whom flammable anesthetics will be used.
  • Adult/pediatric subjects,(greater than 1 year of age) who, at the clinician's discretion, could not tolerate approximately 12, but no more than 25 blood pressures on each extremity
  • Pediatric/neonatal subjects,(less than 1 year of age) who, at the clinician's discretion, could not tolerate approximately 10, but no more than 12 blood pressures on each extremity
  • Presence of pacemaker which makes the atrial fibrillation rhythm indistinguishable
  • Subject's limb circumference is outside of the manufacturer's recommended cuff range
  • Subject has Korotkoff sounds that persist to nearly zero (when applicable)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

GE Healthcare

Tampa, Florida, 33614, United States

Location

MeSH Terms

Conditions

Respiratory Aspiration

Condition Hierarchy (Ancestors)

Respiration DisordersRespiratory Tract DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Jean D Sesing

    GE Healthcare

    STUDY DIRECTOR
0

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 5, 2008

First Posted

August 8, 2008

Study Start

October 1, 2001

Primary Completion

March 1, 2010

Study Completion

May 1, 2010

Last Updated

August 8, 2017

Record last verified: 2017-08

Locations